Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Analytical and Bioanalytical Chemistry|March 12, 2025
Development of polymer monolith-MOF hybrid via surface functionalization for bioanalytical sciencesKinza Ali, Iqra Munawar, Sara Manan, et al.
RSC Advances|December 11, 2025
Unveiling coumarone resin as a tackifier in SBS-based PSA systems-a comprehensive viscoelasticity studyKinza Ali, Iqra Munawar, Faryal Aftab, et al.
Vaccines|December 23, 2023
Assessing Barriers to Human Papillomavirus (HPV) Vaccination in At-Risk Rural Communities of Western North Carolina, United StatesCandice J McNeil, Breona Barr, Iqra Munawar, et al.
Vaccine|September 18, 2022
Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research PartnershipDeAnna J Friedman-Klabanoff, Ashley H Tjaden, Michele Santacatterina, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 27, 2023
Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?Tyler J Stone, Michael DeWitt, James W Johnson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 21, 2022
Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research PartnershipCharles T Semelka, Michael E DeWitt, Kathryn E Callahan, et al.
Vaccines|August 28, 2021
Changing Attitudes toward the COVID-19 Vaccine among North Carolina Participants in the COVID-19 Community Research PartnershipChukwunyelu H Enwezor, James E Peacock, Austin L Seals, et al.
Plos One|March 18, 2022
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research PartnershipJohn C Williamson, Thomas F Wierzba, Michele Santacatterina, et al.
Vaccines|November 24, 2022
Breakthrough SARS-CoV-2 Infections after Vaccination in North CarolinaDiane Uschner, Matthew Bott, William H Lagarde, et al.
Pageof 1